Effects of α-mangostin on apoptosis induction of human colon cancer

World Journal of Gastroenterology

Volumn 17, Issue 16, 2011, Pages 2086-2095

  Watanapokasin, Ramida ^a   Jarinthanan, Faongchat ^b   Nakamura, Yukio ^c   Sawasjirakij, Nitisak ^d   Jaratrungtawee, Amornmart ^a   Suksamrarn, Sunit ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b Rang sit University   (Thailand)

^c NATIONAL HOSPITAL ORGANIZATION MURAYAMA MEDICAL CENTER   (Japan)

^d BANGKOK UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Caspases; Colon cancer; Mitochondria; mangostin

Indexed keywords

ALPHA MANGOSTIN; ANTINEOPLASTIC AGENT; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CELL PROTEIN; CYTOCHROME C; FAS ANTIGEN; GARCINIA MANGOSTANA EXTRACT; INITIATOR CASPASE; PHOSPHATIDYLSERINE; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN BMF; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CHROMATIN CONDENSATION; COLON CANCER; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; ENZYME ACTIVATION; GARCINIA MANGOSTANA; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; WESTERN BLOTTING;

EID: 79955932364     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i16.2086     Document Type: Article

References (33)

1. Mahabusarakam W, Wiriyachitra P, Taylor WC. Chemical constituents of garcinia mangostana. J Nat Prod 1987; 50: 474-478
2. Peres V, Nagem TJ. Trioxygenated naturally occurring xan-thones. Phytochemistry 1997; 44: 191-214
3. Peres V, Nagem TJ, de Oliveira FF. Tetraoxygenated naturally occurring xanthones. Phytochemistry 2000; 55: 683-710
4. Suksamrarn S, Suwannapoch N, Phakhodee W, Thanuhiranlert J, Ratananukul P, Chimnoi N, Suksamrarn A. Antimy-cobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem Pharm Bull (Tokyo) 2003; 51: 857-859
5. Gopalakrishnan G, Banumathi B, Suresh G. Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives. J Nat Prod 1997; 60: 519-524
6. Williams P, Ongsakul M, Proudfoot J, Croft K, Beilin L. Mangostin inhibits the oxidative modifcation of human low density lipoprotein. Free Radic Res 1995; 23: 175-184
7. Jung HA, Su BN, Keller WJ, Mehta RG, Kinghorn AD. Anti-oxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem 2006; 54: 2077-2082
8. Mahabusarakam W, Proudfoot J, Taylor W, Croft K. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic Res 2000; 33: 643-659
9. Ho CK, Huang YL, Chen CC. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines. Planta Med 2002; 68: 975-979
10. Matsumoto K, Akao Y, Ohguchi K, Ito T, Tanaka T, Iinuma M, Nozawa Y. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg Med Chem 2005; 13: 6064-6069
11. Nakagawa Y, Iinuma M, Naoe T, Nozawa Y, Akao Y. Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonucle-ase-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg Med Chem 2007; 15: 5620-5628
12. Suksamrarn S, Komutiban O, Ratananukul P, Chimnoi N, Lartpornmatulee N, Suksamrarn A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem Pharm Bull (Tokyo) 2006; 54: 301-305
13. Chen CN, Hsieh FJ, Cheng YM, Chang KJ, Lee PH. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. J Surg Oncol 2006; 94: 226-233
14. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88: 347-354
15. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462
16. Leist M, Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2: 589-598
17. Rudner J, Lepple-Wienhues A, Budach W, Berschauer J, Fried-rich B, Wesselborg S, Schulze-Osthoff K, Belka C. Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J Cell Sci 2001; 114: 4161-4172
18. Nencioni A, Lauber K, Grünebach F, Van Parijs L, Denzlinger C, Wesselborg S, Brossart P. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. J Immunol 2003; 171: 5148-5156
19. Castedo M, Ferri K, Roumier T, Métivier D, Zamzami N, Kroemer G. Quantitation of mitochondrial alterations associated with apoptosis. J Immunol Methods 2002; 265: 39-47
20. Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci USA 1999; 96: 10964-10967
21. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drum-mond AH, Nagata S. Fas ligand in human serum. Nat Med 1996; 2: 317-322
22. Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY, Lenardo MJ. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 2000; 288: 2354-2357
23. Scaffdi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/ Fas) signaling pathways. EMBO J 1998; 17: 1675-1687
24. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501
25. Watanapokasin R, Jarinthanan F, Jerusalmi A, Suksamrarn S, Nakamura Y, Sukseree S, Uthaisang-Tanethpongtamb W, Ratananukul P, Sano T. Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: caspasedependent apoptosis induction in vitro and in mice. Appl Biochem Biotechnol 2010; 162: 1080-1094
26. Tamatani T, Azuma M, Motegi K, Takamaru N, Kawashima Y, Bando T. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells. Int J Oncol 2007; 31: 761-768
27. Nojima H. Cell cycle checkpoints, chromosome stability and the progression of cancer. Hum Cell 1997; 10: 221-230
28. Lopéz L, Villavicencio MA, Albores A, Martínez M, de la Garza J, Meléndez-Zajgla J, Maldonado V. Cupressus lusitanica (Cupressaceae) leaf extract induces apoptosis in cancer cells. J Ethnopharmacol 2002; 80: 115-120
29. Diaz C, Schroit AJ. Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol 1996; 151: 1-9
30. Earnshaw WC. Nuclear changes in apoptosis. Curr Opin Cell Biol 1995; 7: 337-343
31. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326 (Pt 1): 1-16
32. Kantrow SP, Piantadosi CA. Release of cytochrome c from liver mitochondria during permeability transition. Biochem Biophys Res Commun 1997; 232: 669-671
33. Terrones O, Antonsson B, Yamaguchi H, Wang HG, Liu J, Lee RM, Herrmann A, Basañez G. Lipidic pore formation by the concerted action of proapoptotic BAX and tBID. J Biol Chem 2004; 279: 30081-30091